Celularity (CELU) Stock Price Overview - Stock Analysis About CELU Celularity Inc , a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn’s disease
Celularity Inc - Ordinary Shares - Class A (CELU) Stock Price . . . Track Celularity Inc - Ordinary Shares - Class A (CELU) Stock Price, Quote, latest community messages, chart, news and other stock related information Share your ideas and get valuable insights from the community of like minded traders and investors
Celularity Inc (CELU) Stock Price News - Google Finance Get the latest Celularity Inc (CELU) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions
Celularity – The Next Evolution in Cellular Medicine Celularity Inc (NASDAQ: CELU) is an innovative regenerative and cellular medicine company It is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta
CELU Stock Price Quote | Morningstar CELU is trading within a range we consider fairly valued Price $1 76 Jun 16, 2025 Fair Value $2 71 Jun 14, 2025 Uncertainty High 1-Star Price $4 52 5-Star Price $1 62
Celularity Inc. Class A Common Stock (CELU) - Nasdaq Discover real-time Celularity Inc Class A Common Stock (CELU) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions Stay ahead with Nasdaq